.jpg?width=690&height=468&name=AI-ML-in-life-sciences%20(1).jpg)
Numerous publications, blogs, etc. have reported how quickly the pharmaceutical industry is changing and how manufacturers need to modify their approaches and structures to survive the competition. The pace of change necessitates that Pharma companies undergo a transformation; with organizations expanding the capabilities of their commercial models through smarter experimentation, scalable measurement, faster learning, and dynamic decision making regarding their commercial models.
A transformation of this nature is not necessarily easy to implement. A number of barriers may need to be addressed as Pharma organizations look to experiment and adapt their commercial model. Corporate cultures, infrastructure, and established processes need to be reviewed, evaluated, and perhaps modified.
This white paper discusses the challenges and potential approaches around creating a “continuously experimenting, continuously learning, continuously adapting” organization.
Click here to get the whitepaper